FATTOUM Senda
| Position | Assistant Professor |
| Academic department | Strategy & Entrepreneurship |
| Contact | s.fattoum-belkhouja@montpellier-bs.com |
Dr. Senda Fattoum, an Assistant Professor at Montpellier Business School, stands out for her exceptional expertise in teaching courses such as The Business of Knowledge and Strategic Management in the science-based industry. Holding a Doctor of Philosophy in Business Administration with a specialization in "Management, Technology, and Strategy" from Grenoble Ecole de Management, her academic journey includes an MPhil in Genomics and personalized medicine, a master’s degree in human pathologies from Aix-Marseille University, and an advanced master’s in the management of the biotech industry.
With a foundation in pharmaceutical sciences, Dr. Fattoum has amassed diverse professional experience, obtaining a Doctor of Pharmacy at Monastir, Tunisia, and gaining valuable insights through roles in both the biotech industry and hospital settings. Her research endeavors revolve around knowledge production, with a dual focus on academia and the biotech and pharma industries. Driven by a passion for unraveling the intricacies of the innovation process and fostering cross-functional collaboration under conditions of uncertainty, she extends her research interests to the public health sector, examining knowledge production through patient partnerships. As an educator and researcher, Dr. Fattoum seamlessly blends academic rigor with practical industry experience, contributing significantly to the dynamic intersection of academia and the business world.
FATTOUM-BELKHOUJA, S. - "To make it or to buy it: Investing in M&A or R&D as contradictory or complementary strategies in the biotech and pharma industries" - 2024, In M. Thomas & J.L. Rose (Eds.), Mergers and Acquisitions: The Pharmaceutical and Biotechnology Industries. Routledge, Taylor & Francis
BELKOUJA, M., S. FATTOUM-BELKHOUJA, D. Y. HYUNGSEOK, "Does greater diversification increase individual productivity? The moderating effect of attention allocation.", Research Policy, March 2021, vol. 104256, no. 50(6)
Strategic management, Social entrepreneurship, Quality, Health, Safety and Environment, Organizational behavior, Knowledge management, Innovation management, Business model - Pharmaceutical industry, Professional, scientific and technical activities, Huma
Strategy, Management and organisation, Organizations
